Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss was successfully treated with the drug adalimumab.

Atopic dermatitis increases the risk of some autoimmune diseases.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Alopecia linked to higher anxiety and personality disorders.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Rat dermal papilla cells have unique genes crucial for hair growth.

Scientists can now create skin with hair by reprogramming cells in wounds.

FLCN helps control iron levels in cells.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.